• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可变剪接与发育和癌症中的表型可塑性之间的复杂联系。

An Intricate Connection between Alternative Splicing and Phenotypic Plasticity in Development and Cancer.

机构信息

Institute of Molecular Genetics (IGM); National Research Council (CNR), 27100 Pavia, Italy.

SYSBIO.IT, Centre of Systems Biology, University of Milano-Bicocca, 20126 Milano, Italy.

出版信息

Cells. 2019 Dec 21;9(1):34. doi: 10.3390/cells9010034.

DOI:10.3390/cells9010034
PMID:31877720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7016785/
Abstract

During tumor progression, hypoxia, nutrient deprivation or changes in the extracellular environment (i.e., induced by anti-cancer drugs) elicit adaptive responses in cancer cells. Cellular plasticity increases the chance that tumor cells may survive in a challenging microenvironment, acquire new mechanisms of resistance to conventional drugs, and spread to distant sites. Re-activation of stem pathways appears as a significant cause of cellular plasticity because it promotes the acquisition of stem-like properties through a profound phenotypic reprogramming of cancer cells. In addition, it is a major contributor to tumor heterogeneity, depending on the coexistence of phenotypically distinct subpopulations in the same tumor bulk. Several cellular mechanisms may drive this fundamental change, in particular, high-throughput sequencing technologies revealed a key role for alternative splicing (AS). Effectively, AS is one of the most important pre-mRNA processes that increases the diversity of transcriptome and proteome in a tissue- and development-dependent manner. Moreover, defective AS has been associated with several human diseases. However, its role in cancer cell plasticity and tumor heterogeneity remains unclear. Therefore, unravelling the intricate relationship between AS and the maintenance of a stem-like phenotype may explain molecular mechanisms underlying cancer cell plasticity and improve cancer diagnosis and treatment.

摘要

在肿瘤进展过程中,缺氧、营养缺乏或细胞外环境的变化(例如,由抗癌药物引起的)会引发癌细胞的适应性反应。细胞可塑性增加了肿瘤细胞在具有挑战性的微环境中存活、获得对传统药物新的耐药机制以及扩散到远处部位的机会。干细胞途径的重新激活似乎是细胞可塑性的一个重要原因,因为它通过对癌细胞进行深刻的表型重编程来促进获得类似干细胞的特性。此外,它是肿瘤异质性的主要贡献者,这取决于同一肿瘤块中存在表型不同的亚群。几种细胞机制可能驱动这种根本变化,特别是高通量测序技术揭示了选择性剪接 (AS) 的关键作用。实际上,AS 是最重要的前体 RNA 加工之一,它以组织和发育依赖的方式增加转录组和蛋白质组的多样性。此外,有缺陷的 AS 与几种人类疾病有关。然而,它在癌细胞可塑性和肿瘤异质性中的作用尚不清楚。因此,揭示 AS 与维持类似干细胞的表型之间的复杂关系可能有助于解释癌细胞可塑性的分子机制,并改善癌症的诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/7016785/b08ae72bdf56/cells-09-00034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/7016785/aa925660bb65/cells-09-00034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/7016785/1da4fa865e76/cells-09-00034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/7016785/b08ae72bdf56/cells-09-00034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/7016785/aa925660bb65/cells-09-00034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/7016785/1da4fa865e76/cells-09-00034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0187/7016785/b08ae72bdf56/cells-09-00034-g003.jpg

相似文献

1
An Intricate Connection between Alternative Splicing and Phenotypic Plasticity in Development and Cancer.可变剪接与发育和癌症中的表型可塑性之间的复杂联系。
Cells. 2019 Dec 21;9(1):34. doi: 10.3390/cells9010034.
2
Cancer cell plasticity: Impact on tumor progression and therapy response.肿瘤细胞的可塑性:对肿瘤进展和治疗反应的影响。
Semin Cancer Biol. 2018 Dec;53:48-58. doi: 10.1016/j.semcancer.2018.08.009. Epub 2018 Aug 18.
3
Tumor-associated macrophages and epithelial-mesenchymal transition in cancer: Nanotechnology comes into view.肿瘤相关巨噬细胞与癌症中的上皮-间质转化:纳米技术崭露头角。
J Cell Physiol. 2018 Dec;233(12):9223-9236. doi: 10.1002/jcp.27027. Epub 2018 Aug 5.
4
HGF/c-Met Signalling in the Tumor Microenvironment.肿瘤微环境中的 HGF/c-Met 信号通路。
Adv Exp Med Biol. 2021;1270:31-44. doi: 10.1007/978-3-030-47189-7_2.
5
Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells.信号蛋白作为癌细胞表型可塑性和功能重编程的调控因子。
Trends Mol Med. 2019 Apr;25(4):303-314. doi: 10.1016/j.molmed.2019.01.010. Epub 2019 Feb 26.
6
Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.缺氧应激在调节肿瘤免疫原性、耐药性和可塑性中的作用。
Int J Mol Sci. 2018 Oct 6;19(10):3044. doi: 10.3390/ijms19103044.
7
EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.上皮-间质转化与干性:在发育和癌症进展中由可变剪接调节的灵活过程
Mol Cancer. 2017 Jan 30;16(1):8. doi: 10.1186/s12943-016-0579-2.
8
Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.上皮、间充质和混合上皮/间充质表型及其在癌症转移中的临床相关性。
Expert Rev Mol Med. 2017 Mar 21;19:e3. doi: 10.1017/erm.2017.6.
9
Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.上皮-内皮转化与癌症干细胞:恶性肿瘤中血管生成拟态的两大基石。
Oncotarget. 2017 May 2;8(18):30502-30510. doi: 10.18632/oncotarget.8461.
10
Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance.乳腺癌干细胞的上皮-间质可塑性:对转移和治疗抗性的影响
Curr Pharm Des. 2015;21(10):1301-10. doi: 10.2174/1381612821666141211120604.

引用本文的文献

1
CPSF4-mediated regulation of alternative splicing of HMG20B facilitates the progression of triple-negative breast cancer.CPSF4介导的HMG20B可变剪接调控促进三阴性乳腺癌进展。
J Transl Med. 2024 Dec 27;22(1):1149. doi: 10.1186/s12967-024-06004-x.
2
Introns and Their Therapeutic Applications in Biomedical Researches.内含子及其在生物医学研究中的治疗应用。
Iran J Biotechnol. 2023 Oct 1;21(4):e3316. doi: 10.30498/ijb.2023.334488.3316. eCollection 2023 Oct.
3
Comparative RNA-Seq Analysis Revealed Tissue-Specific Splicing Variations during the Generation of the PDX Model.

本文引用的文献

1
Tumor angiogenesis: causes, consequences, challenges and opportunities.肿瘤血管生成:原因、后果、挑战与机遇。
Cell Mol Life Sci. 2020 May;77(9):1745-1770. doi: 10.1007/s00018-019-03351-7. Epub 2019 Nov 6.
2
CD44 splice isoform switching determines breast cancer stem cell state.CD44 剪接异构体转换决定乳腺癌干细胞状态。
Genes Dev. 2019 Feb 1;33(3-4):166-179. doi: 10.1101/gad.319889.118. Epub 2019 Jan 28.
3
A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells.一个 VEGF-A/SOX2/SRSF2 网络控制着肺癌细胞中 VEGFR1 前体 mRNA 的可变剪接。
比较 RNA-Seq 分析揭示了 PDX 模型生成过程中组织特异性剪接变化。
Int J Mol Sci. 2023 Nov 30;24(23):17001. doi: 10.3390/ijms242317001.
4
Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.核 PTEN 在抑制肿瘤发生中的作用:对罕见癌症的启示。
Biomolecules. 2023 Jan 30;13(2):259. doi: 10.3390/biom13020259.
5
Post-Transcriptional Modification by Alternative Splicing and Pathogenic Splicing Variants in Cardiovascular Development and Congenital Heart Defects.转录后修饰通过选择性剪接和致病性剪接变体在心血管发育和先天性心脏缺陷中的作用。
Int J Mol Sci. 2023 Jan 13;24(2):1555. doi: 10.3390/ijms24021555.
6
Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer.EMT 下游的可变剪接增强了结肠癌的表型可塑性和恶性行为。
Elife. 2022 Nov 8;11:e82006. doi: 10.7554/eLife.82006.
7
Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk.解读三种RNA剪接相关基因变异与肺癌风险之间的关联。
NPJ Precis Oncol. 2022 Jun 30;6(1):48. doi: 10.1038/s41698-022-00281-9.
8
Role of RNA Splicing in Regulation of Cancer Stem Cell.RNA剪接在癌症干细胞调控中的作用
Curr Stem Cell Res Ther. 2023;18(1):3-6. doi: 10.2174/1574888X16666211207103628.
9
Comprehensive Combined Proteomics and Genomics Analysis Identifies Prognostic Related Transcription Factors in Breast Cancer and Explores the Role of DMAP1 in Breast Cancer.综合蛋白质组学和基因组学分析鉴定乳腺癌中与预后相关的转录因子并探索DMAP1在乳腺癌中的作用。
J Pers Med. 2021 Oct 23;11(11):1068. doi: 10.3390/jpm11111068.
10
Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors.胰腺癌细胞系PANC-1中导管向内分泌转分化转录程序的激活由RAC1和RAC1b通过对干性因子的拮抗调控来控制。
Cancers (Basel). 2021 Nov 4;13(21):5541. doi: 10.3390/cancers13215541.
Sci Rep. 2019 Jan 23;9(1):336. doi: 10.1038/s41598-018-36728-y.
4
The Krebs Cycle Connection: Reciprocal Influence Between Alternative Splicing Programs and Cell Metabolism.三羧酸循环关联:可变剪接程序与细胞代谢之间的相互影响
Front Oncol. 2018 Sep 26;8:408. doi: 10.3389/fonc.2018.00408. eCollection 2018.
5
The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.长链非编码 RNA MALAT1 通过调控 RBFOX2 介导的可变剪接促进卵巢癌细胞的进展。
Mol Carcinog. 2019 Feb;58(2):196-205. doi: 10.1002/mc.22919. Epub 2018 Oct 28.
6
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer.癌症剪接体:癌症中可变剪接的重编程
Front Mol Biosci. 2018 Sep 7;5:80. doi: 10.3389/fmolb.2018.00080. eCollection 2018.
7
Alternative splicing links histone modifications to stem cell fate decision.可变剪接将组蛋白修饰与干细胞命运决定联系起来。
Genome Biol. 2018 Sep 14;19(1):133. doi: 10.1186/s13059-018-1512-3.
8
TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency.hnRNP H/F 通过调控 TCF3 的可变剪接影响 E-钙黏蛋白表达和 hESC 多能性。
Genes Dev. 2018 Sep 1;32(17-18):1161-1174. doi: 10.1101/gad.316984.118. Epub 2018 Aug 16.
9
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.对 8705 例肿瘤患者的可变剪接进行全面分析。
Cancer Cell. 2018 Aug 13;34(2):211-224.e6. doi: 10.1016/j.ccell.2018.07.001. Epub 2018 Aug 2.
10
Splicing and transcription touch base: co-transcriptional spliceosome assembly and function.剪接与转录的关联:共转录剪接体的组装与功能
Nat Rev Mol Cell Biol. 2017 Oct;18(10):637-650. doi: 10.1038/nrm.2017.63. Epub 2017 Aug 9.